ΒΙΟΛΟΓΙΚΑ ΠΡΟΪΟΝΤΑ

    公开(公告)号:CY1118713T1

    公开(公告)日:2017-07-12

    申请号:CY171100321

    申请日:2017-03-14

    Abstract: Μιαπρωτεΐνησύντηξηςπολυσθενούςαντισώματοςπουπεριλαμβάνειένατμήμαανοσοσφαιρίνης, παραδείγματοςχάριντα Fab ή Fab', μεμιαπρώτηειδικότηταγιαένααντιγόνοενδιαφέροντος, καιπουεπιπλέονπεριλαμβάνειαντισώματααπλώνπεριοχών (dAb) μεειδικότηταγιαέναδεύτεροαντιγόνοενδιαφέροντος, όπουταδυοαντισώματααπλώνπεριοχώνείναισυνδεδεμέναμεταξύτουςμέσωενόςδισουλφιδικούδεσμού. Παρέχονταιεπίσηςσυγκεκριμένεςπρωτεΐνεςσύντηξηςαντισώματοςδιπλήςειδικότηταςπουπεριέχουνένατμήμα Fab ή Fab' καιέναή περισσότερααντισώματααπλώνπεριοχών, ταοποίαείναισταθεροποιημέναμέσωενόςδισουλφιδικούδεσμού.

    MULTISPECIFIC ANTIBODY CONSTRUCTS
    56.
    发明专利

    公开(公告)号:CA2951609A1

    公开(公告)日:2015-12-30

    申请号:CA2951609

    申请日:2015-06-25

    Abstract: The present disclosure relates to a multi-specific antibody molecule comprising or consisting of: a) a polypeptide chain of formula (I): VH-CH1-X-V1; and b) a polypeptide chain of formula (II): VL-CL-Y-V2 and pharmaceutical formulations comprising, for example for use in treatment. The disclosure also provides polynucleotide sequences encoding said multispecific antibody molecules, vectors comprising the polynucleotides and host cells comprising said vectors and/or polynucleotide sequences. There is a provided a method of expressing a multispecific antibody molecule of the present disclosure from a host cell.

    SINGLE LINKER FABFV ANTIBODIES AND METHODS OF PRODUCING SAME

    公开(公告)号:CA2895608C

    公开(公告)日:2021-05-25

    申请号:CA2895608

    申请日:2013-12-20

    Abstract: The present disclosure relates to a multi-specific antibody molecule comprising or consisting of three polypeptides: a) a polypeptide chain of formula (I):(Vxx)nVx-Cx-X-V1; and b) a polypeptide chain of formula (II): (Vyy)nVy-Cy c) a polypeptide of formula (III):V2 wherein Vx represents a variable domain, Vxx represents a variable domain, Cx represents a constant region, X represents a linker, V represents a variable domain, Vy represents a variable domain, Vyy represents a variable domain, Cy represents a constant region, V2 represents a variable domain, n independently represents 0 or 1, wherein the polypeptide chain of formula (I) and the polypeptide chain of formula (II) is aligned such that the constant regions Cx and Cy are paired and the variable domains Vx and Vy are paired to form a binding domain and optionally a disulphide bond is present between V and V2, in particular where a disulphide bond is present. The disclosure also extends to pharmaceutical formulation comprising the construct, DNA encoding the constructs and vectors comprising same. The disclosure further extends to a method of expressing the constructs, for example in a host cell and methods for formulating same as a pharmaceutical composition. The disclosure also relates to use of the constructs and formulations in treatment.

Patent Agency Ranking